Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Brady

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Toxicological Sciences|February 4, 2021
Development challenges associated with rAAV-based gene therapiesMichael W Bolt, Joseph T Brady, Lawrence O Whiteley, et al.
Toxicologic Pathology|June 11, 2015
Drug-induced Skin Lesions in Cynomolgus Macaques Treated with Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric ModulatorsGopinath S Palanisamy, John M Marcek, Gregg D Cappon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 28, 2012
Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevanceKay A Criswell, Jon C Cook, Zbigniew Wojcinski, et al.
Journal of Medicinal Chemistry|November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studiesTravis T Wager, Bethany L Kormos, Joseph T Brady, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Toxicological Sciences|February 4, 2021
Development challenges associated with rAAV-based gene therapiesMichael W Bolt, Joseph T Brady, Lawrence O Whiteley, et al.
Toxicologic Pathology|June 11, 2015
Drug-induced Skin Lesions in Cynomolgus Macaques Treated with Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric ModulatorsGopinath S Palanisamy, John M Marcek, Gregg D Cappon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 28, 2012
Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevanceKay A Criswell, Jon C Cook, Zbigniew Wojcinski, et al.
Journal of Medicinal Chemistry|November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studiesTravis T Wager, Bethany L Kormos, Joseph T Brady, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Pageof 1